HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis.

Abstract
Mansonella perstans filariasis is widely present in Africa and equatorial America and its pathogenicity has recently been reconsidered. Effective treatment is lacking and there is no consensus on the optimal therapeutic approach. The aim of this study was to compare the effects of different drug regimens on M. perstans infection. Six different anthelminthic therapeutic protocols were undertaken on 165 subjects with M. perstans infection and their effects on microfilariae burden were evaluated. Diethylcarbamazine (DEC) was able to reduce microfilariae density in the majority of cases, but it seldom eliminated infection after a single treatment. Mebendazole appeared to be more active than DEC in eliminating the infection, with a comparable rate of overall responses. Ivermectin and praziquantel showed no modification of microfilariae concentration. Thiabendazole showed a small but significant activity against the infection. Combination treatments (DEC plus mebendazole) resulted in a significantly higher activity than the single drugs.
AuthorsEnrico Rino Bregani, Angelo Rovellini, Narassem Mbaïdoum, Maria Giovanna Magnini
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) Vol. 100 Issue 5 Pg. 458-63 (May 2006) ISSN: 0035-9203 [Print] England
PMID16257021 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Filaricides
  • Praziquantel
  • Ivermectin
  • Mebendazole
  • Thiabendazole
  • Diethylcarbamazine
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Case-Control Studies
  • Chad
  • Child
  • Developing Countries
  • Diethylcarbamazine (therapeutic use)
  • Female
  • Filaricides (therapeutic use)
  • Humans
  • Ivermectin (therapeutic use)
  • Male
  • Mansonella
  • Mansonelliasis (drug therapy, immunology)
  • Mebendazole (therapeutic use)
  • Middle Aged
  • Praziquantel (therapeutic use)
  • Statistics, Nonparametric
  • Thiabendazole (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: